1
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T77010 | Fiztasovimab | ||
Fiztasovimab (NPC-21; EV2038) 是一种全人 IgG1λ 单克隆抗体,具有抗人巨细胞病毒 (hCMV) 活性。Fiztasovimab 通过结合 hCMV 包膜上糖蛋白 B 的抗原结构域 1 发挥中和活性。Fiztasovimab 还抑制 hCMV 的细胞间传播。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-00548 |
Epstein-Barr virus (strain B95-8) BZLF1 Protein (His & SUMO)
Zta,Trans-activator protein BZLF1,Lytic switch prot... |
EBV | E. coli |
Plays a key role in the switch from latent infection to lytic cycle producing new virions. Acts as a transcription factor, inducing early lytic cycle genes, and as a origin binding protein for genome replication. BZLF1 activates the promoter of another EBV gene (BSLF2+BMLF1). | |||
TMPH-00549 |
Epstein-Barr virus (strain GD1) BZLF1 Protein (His & Myc)
bZIP transcription factor ZEBRA,Lytic switch protein BZLF1,T... |
EBV | E. coli |
Plays a key role in the switch from latent infection to lytic cycle producing new virions. Acts as a transcription factor, inducing early lytic cycle genes, and as a origin binding protein for genome replication. BZLF1 activates the promoter of another EBV gene (BSLF2+BMLF1). |